IMC Chicago’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201M Buy
416,200
+181,900
+78% +$68.6M 0.05% 229
2026
Q1
$69.5M Buy
234,300
+55,700
+31% +$15.5M 0.03% 398
2025
Q4
$34.6M Buy
178,600
+44,500
+33% +$7.64M 0.01% 618
2025
Q3
$18.5M Sell
134,100
-64,100
-32% -$7M 0.01% 827
2025
Q2
$17.8M Buy
198,200
+103,300
+109% +$8.25M 0.01% 751
2025
Q1
$7.84M Sell
94,900
-21,700
-19% -$2.43M ﹤0.01% 997
2024
Q4
$14.7M Buy
116,600
+79,600
+215% +$9.42M 0.01% 742
2024
Q3
$4.96M Sell
37,000
-22,300
-38% -$3.01M ﹤0.01% 1134
2024
Q2
$8.79M Buy
59,300
+42,400
+251% +$5.39M 0.01% 827
2024
Q1
$1.91M Buy
+16,900
New +$1.76M ﹤0.01% 1387

Other funds holding TER

IMC Chicago's TER Position: Q2 2026 in Review

IMC Chicago sold out of Teradyne (TER) in Q2 2026, closing a stake of 63,952 shares — an estimated $24.1M sold.

IMC Chicago first reported a position in TER in Q2 2025 and held it in 3 quarters. The position peaked at $19M in Q1 2026. 1,424 funds tracked by Wall St. Rank hold TER as of Q2 2026.

  • IMC Chicago reported no remaining Teradyne position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 63,952 Teradyne shares in Q2 2026, an estimated $24.1M.
  • IMC Chicago first reported a position in Teradyne in Q2 2025 and held it in 3 quarters.
  • IMC Chicago's Teradyne position peaked at $19M in Q1 2026.
  • 1,424 funds tracked by Wall St. Rank held Teradyne as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.